Venotur Jambes fatiguées (30 comprimés)
Food supplement declared in France, decision dated 24 January 2025
Venotur Jambes fatiguées (30 comprimés) (Novonatur) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: diosmine 28.8 mg per day, Aesculus hippocastanum 250 mg per day, Ruscus aculeatus 160 mg per day, Centella asiatica 100 mg per day, Citrus aurantium 12 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Novonatur
- Food business operator placing the product on the market
- NOVO MARKETING PLUS S.L.
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Tablet
- Daily dose
- 1 comprimé
- Directions for use
- Prendre 1 comprimé par jour au petit-déjeuner.
- Intended populations
- General population
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Pregnant women, High blood pressure, Taking medication
- Objectives stated by the manufacturer (these are not authorised claims)
- Blood and lymphatic circulation
Declaration 5047, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Aesculus hippocastanum L. | Graine | Extrait sec aqueux | 250 mg |
| Ruscus aculeatus L. | Racine | Extrait sec aqueux | 160 mg |
| Centella asiatica (L.) Urb. | Parties aériennes | Extrait sec aqueux | 100 mg |
| Citrus aurantium L. | Fruit | Extrait sec aqueux | 12 mg |
Substances
| Name | Per day |
|---|---|
| diosmine | 28.8 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| sodium-L-ascorbate | Vitamin C | no limit (insufficient data) | 180 mg |
Additives
E551, E470b, E341, E466, E463, E953, E460
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Les compléments alimentaires ne doivent pas être utilisés comme substituts à une alimentation équilibrée. Il est important d’avoir une alimentation variée et équilibrée et un mode de vie sain. Ne dépassez pas la dose journalière expressément recommandée. Tenir hors de portée des petits enfants. Déconseillé pendant la grossesse, l'allaitement, les enfants de moins de 12 ans et les personnes sous traitement contre l'hypertension. Chez les personnes traitées par des anticoagulants et/ou des agents antiplaquettaires, consultez votre médecin avant de consommer le produit.
Regulatory points
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Aesculus hippocastanum L.
Read the warning, when it applies and the studies cited
Horse Chestnut - Aesculus Hippocastanum
Route of administration: Oral (Bradley 2006; ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Novonatur
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Venotur Jambes fatiguées (30 comprimés) (Novonatur): composition and regulation”, https://compoatlas.com/en/supplements/products/5047-venotur-jambes-fatiguees-30-comprimes, updated 15 November 2026.